Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report

Abstract Background Achondroplasia (ACH), the most common form of short‐limbed skeletal dysplasia, is caused by gain‐of‐function mutations in the fibroblast growth factor receptor 3 (FGFR3) gene. More than 97% of patients result from a heterozygous p.G380R mutation in the FGFR3 gene. We present here...

Full description

Bibliographic Details
Main Authors: Tadashi Nagata, Masaki Matsushita, Kenichi Mishima, Yasunari Kamiya, Kohji Kato, Miho Toyama, Tomoo Ogi, Naoki Ishiguro, Hiroshi Kitoh
Format: Article
Language:English
Published: Wiley 2020-03-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
Online Access:https://doi.org/10.1002/mgg3.1148
_version_ 1797301061860458496
author Tadashi Nagata
Masaki Matsushita
Kenichi Mishima
Yasunari Kamiya
Kohji Kato
Miho Toyama
Tomoo Ogi
Naoki Ishiguro
Hiroshi Kitoh
author_facet Tadashi Nagata
Masaki Matsushita
Kenichi Mishima
Yasunari Kamiya
Kohji Kato
Miho Toyama
Tomoo Ogi
Naoki Ishiguro
Hiroshi Kitoh
author_sort Tadashi Nagata
collection DOAJ
description Abstract Background Achondroplasia (ACH), the most common form of short‐limbed skeletal dysplasia, is caused by gain‐of‐function mutations in the fibroblast growth factor receptor 3 (FGFR3) gene. More than 97% of patients result from a heterozygous p.G380R mutation in the FGFR3 gene. We present here a child who had two de novo variants in the FGFR3 on the same allele, a common p.G380R mutation and a novel p.S378N variant. Methods A 3‐year‐old Japanese girl born from non‐consanguineous healthy parents showed more severe clinical and radiological phenotypes than classic ACH, including severe short‐limbed short stature with marked ossification defects in the metaphysis and epiphysis, hydrocephalus and cervicomedullary compression due to foramen magnum stenosis, prolonged pulmonary hypoplasia, and significant delay in the gross motor development. Genomic DNA was extracted from the proband and whole‐exome sequencing was performed. The variants were subsequently confirmed by Sanger sequencing. Results Mutation analysis demonstrated that the proband had p.S378N (c.1133G>A) and p.G380R (c.1138G>A) variants in the FGFR3 gene. Both variants were not detected in her parents and therefore considered de novo. An allele‐specific PCR was developed in order to determine whether these mutations were on the same allele (cis) or on different alleles (trans). The c.1138G>A mutation was found in the PCR product generated with the primer for the mutant 1133A, but it was not detected in the product with the wild‐type 1133G, confirming that p.S378N and p.G380R variants were located on the same allele (cis). Conclusion This is the second case who had two FGFR3 variants in the transmembrane domain on the same allele. The p.S378N variant may provide an additive effect on the activating receptor with the p.G380R mutation and alter the protein function, which could be responsible for the severe phenotype of the present case.
first_indexed 2024-03-07T23:16:58Z
format Article
id doaj.art-6c57499fa41845d598302f1439131a92
institution Directory Open Access Journal
issn 2324-9269
language English
last_indexed 2024-03-07T23:16:58Z
publishDate 2020-03-01
publisher Wiley
record_format Article
series Molecular Genetics & Genomic Medicine
spelling doaj.art-6c57499fa41845d598302f1439131a922024-02-21T10:43:38ZengWileyMolecular Genetics & Genomic Medicine2324-92692020-03-0183n/an/a10.1002/mgg3.1148Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case reportTadashi Nagata0Masaki Matsushita1Kenichi Mishima2Yasunari Kamiya3Kohji Kato4Miho Toyama5Tomoo Ogi6Naoki Ishiguro7Hiroshi Kitoh8Department of Orthopaedic Surgery Nagoya University Graduate School of Medicine Nagoya JapanDepartment of Orthopaedic Surgery Nagoya University Graduate School of Medicine Nagoya JapanDepartment of Orthopaedic Surgery Nagoya University Graduate School of Medicine Nagoya JapanDepartment of Orthopaedic Surgery Nagoya University Graduate School of Medicine Nagoya JapanDepartment of Genetics Research Institute of Environmental Medicine (RIeM) Nagoya University Nagoya JapanDepartment of Genetics Research Institute of Environmental Medicine (RIeM) Nagoya University Nagoya JapanDepartment of Genetics Research Institute of Environmental Medicine (RIeM) Nagoya University Nagoya JapanDepartment of Orthopaedic Surgery Nagoya University Graduate School of Medicine Nagoya JapanDepartment of Orthopaedic Surgery Nagoya University Graduate School of Medicine Nagoya JapanAbstract Background Achondroplasia (ACH), the most common form of short‐limbed skeletal dysplasia, is caused by gain‐of‐function mutations in the fibroblast growth factor receptor 3 (FGFR3) gene. More than 97% of patients result from a heterozygous p.G380R mutation in the FGFR3 gene. We present here a child who had two de novo variants in the FGFR3 on the same allele, a common p.G380R mutation and a novel p.S378N variant. Methods A 3‐year‐old Japanese girl born from non‐consanguineous healthy parents showed more severe clinical and radiological phenotypes than classic ACH, including severe short‐limbed short stature with marked ossification defects in the metaphysis and epiphysis, hydrocephalus and cervicomedullary compression due to foramen magnum stenosis, prolonged pulmonary hypoplasia, and significant delay in the gross motor development. Genomic DNA was extracted from the proband and whole‐exome sequencing was performed. The variants were subsequently confirmed by Sanger sequencing. Results Mutation analysis demonstrated that the proband had p.S378N (c.1133G>A) and p.G380R (c.1138G>A) variants in the FGFR3 gene. Both variants were not detected in her parents and therefore considered de novo. An allele‐specific PCR was developed in order to determine whether these mutations were on the same allele (cis) or on different alleles (trans). The c.1138G>A mutation was found in the PCR product generated with the primer for the mutant 1133A, but it was not detected in the product with the wild‐type 1133G, confirming that p.S378N and p.G380R variants were located on the same allele (cis). Conclusion This is the second case who had two FGFR3 variants in the transmembrane domain on the same allele. The p.S378N variant may provide an additive effect on the activating receptor with the p.G380R mutation and alter the protein function, which could be responsible for the severe phenotype of the present case.https://doi.org/10.1002/mgg3.1148achondroplasiaallele‐specific PCRexome sequencingFGFR3skeletal dysplasia
spellingShingle Tadashi Nagata
Masaki Matsushita
Kenichi Mishima
Yasunari Kamiya
Kohji Kato
Miho Toyama
Tomoo Ogi
Naoki Ishiguro
Hiroshi Kitoh
Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report
Molecular Genetics & Genomic Medicine
achondroplasia
allele‐specific PCR
exome sequencing
FGFR3
skeletal dysplasia
title Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report
title_full Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report
title_fullStr Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report
title_full_unstemmed Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report
title_short Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report
title_sort severe achondroplasia due to two de novo variants in the transmembrane domain of fgfr3 on the same allele a case report
topic achondroplasia
allele‐specific PCR
exome sequencing
FGFR3
skeletal dysplasia
url https://doi.org/10.1002/mgg3.1148
work_keys_str_mv AT tadashinagata severeachondroplasiaduetotwodenovovariantsinthetransmembranedomainoffgfr3onthesamealleleacasereport
AT masakimatsushita severeachondroplasiaduetotwodenovovariantsinthetransmembranedomainoffgfr3onthesamealleleacasereport
AT kenichimishima severeachondroplasiaduetotwodenovovariantsinthetransmembranedomainoffgfr3onthesamealleleacasereport
AT yasunarikamiya severeachondroplasiaduetotwodenovovariantsinthetransmembranedomainoffgfr3onthesamealleleacasereport
AT kohjikato severeachondroplasiaduetotwodenovovariantsinthetransmembranedomainoffgfr3onthesamealleleacasereport
AT mihotoyama severeachondroplasiaduetotwodenovovariantsinthetransmembranedomainoffgfr3onthesamealleleacasereport
AT tomooogi severeachondroplasiaduetotwodenovovariantsinthetransmembranedomainoffgfr3onthesamealleleacasereport
AT naokiishiguro severeachondroplasiaduetotwodenovovariantsinthetransmembranedomainoffgfr3onthesamealleleacasereport
AT hiroshikitoh severeachondroplasiaduetotwodenovovariantsinthetransmembranedomainoffgfr3onthesamealleleacasereport